This visit to Japan was organized by the Development Center for Biotechnology (DCB) and the Biotechnology and Pharmaceutical Industries Promotion Office (BPIPO) of the Ministry of Economic Affairs. The itinerary included visits to Japanese medical clinics, cell contract manufacturing organizations, the Forum for Innovative Regenerative Medicine (FIRM), and several start-up companies. From April 23 to April 25, Medigen took part in multiple Taiwan–Japan exchange activities as a member of the visiting group.



GeneOnline event coverage link:
MOEA Taiwan Biotech Visiting Group Visits Japan, Showcasing Taiwan's Strength in Regenerative Medicine (in Chinese)